Validity and Reliability of the Polar M200 Activity Monitor

Fitness Trackers Clinical Trial

— VAPO  

Official title:

Validity and Reliability of the Polar M200 Activity Monitor to Measure Sedentary and Active Time

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05077995
• Other study ID #: VAPO-UH
• Status: Completed
• Phase: N/A
• Start date: July 25, 2021
• Est. completion date: May 1, 2022

Study information

• Verified date: May 2022
• Source: Hasselt University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study will be to investigate the validity of a consumer available activity tracker (Polar M200) in free-living conditions to measure sedentary time.

Description:

The aim of the present study is to evaluate the validity from a commercially available wearable Polar device. Consumer-based activity trackers are generally cheaper, designed for long-term wear and are less intrusive. Potentially, consumer-based activity trackers can be used for research purposes, but high-quality validation studies are needed. The aims of this study will be to assess validity of sedentary outcome measures of a Polar device during free-living conditions in comparison with the ActivPAL3TM activity monitor (AP; PAL Technologies Ltd, Glasgow, UK), which is considered the gold standard to measure sedentary time in free-living conditions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: May 1, 2022
• Est. primary completion date: May 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Healthy adults

Exclusion Criteria:

• /

Related Conditions & MeSH terms

• Fitness Trackers
• Healthy Persons

Intervention

Device:
• Polar M200
Participants will have to wear the activity monitors (AP and Polar M200) for at least 7 days. Minutes spent in each activity type will be summed to a total day score. Participants will be instructed to do their regular daily life activities without limitation, but to note their main activity categories in an activity diary, with a main focus on cycling and participation in structured exercise.

Locations

Country	Name	City	State
Belgium	Hasselt University	Hasselt	Limburg

Sponsors (1)

Lead Sponsor	Collaborator
Hasselt University

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sedentary time	Sedentary time	7 days
Secondary	Steps	Number of steps	7 days
Secondary	Sleeping time	Sleeping time	7 days
Secondary	Standing time	Standing time	7 days
Secondary	Walking time	Walking and running time	7 days